EUROCARE-3: Survival Analysis 1990-1994

Eurocare 3 Survival Analysis 1990-1994
Eurocare 3 Survival Analysis 1990-1994
Cancer Site Population Age Class
Acute lymphatic leukaemia Melanoma of skin
Acute myeloid leukaemia Multiple myeloma
ALL CANCERS Nasal cavities
Bladder Nasopharynx
Bone Non-Hodgkin's lymphomas
Brain Oesophagus
Breast Oral cavity
Cervix uteri Oropharynx
Choroid (melanoma) Ovary
Chronic lymphatic leukaemia Pancreas
Chronic myeloid leukaemia Penis
Colon Pleura
Corpus uteri Prostate
Biliary tract Rectum
Head & Neck Salivary glands
Hodgkin's disease Small intestine
Hypopharynx Soft tissues
Kidney Stomach
Larynx Testis
Leukaemia Thyroid gland
Lip Tongue
Liver, Primary Vagina and vulva
Lung Colon and Rectum
Tyrol Latina Sweden
Denmark Modena Basel
Eindhoven Parma Geneva
Dutch Registries Ragusa Swiss Registries
East Anglia Romagna Amsterdam
Mersey Turin SouthWest
Oxford Varese Thames
West Midlands Italian Registries Trent
Yorkshire Cracow Malta
English Registries Warsaw Portugal
Estonia Polish Registries Wales
Finland Scotland Bas Rhin
Calvados Slovakia Murcia
Côte d'Or Slovenia West Bohemia
Isère Basque Country Sassari
French Registries Granada Norway
Saarland Mallorca Ferrara
Iceland Navarra Macerata
Tuscany Tarragona Munich
Genoa Spanish Registries Veneto
Europe
Sex
Male Female Male and Female
15-44
45-54
55-64
65-74
75-99
All ages 15-99
Eurocare-3 standard
ICSS standard
20-44
20-99
15-54
75-84
85-99
Time from diagnosis
1 year
2 years
3 years
4 years
5 years
Period of Diagnosis
Output Indicators
Number of cases Observed Survival, Interval (OSI) Relative Survival, Interval (RSI) Relative SE's, Interval (RSEI)
Alive at Start Observed Survival, Cum (OSC) Relative Survival, Cum (RSC) Relative SE's, Cum (RSEC)
Dead Expected Survival, Interval (ESI) Observed SE's, Interval (OSEI) RSC: Lower bound
Lost to Follow Up Expected Survival, Cum (ESC) Observed SE's, Cum (OSEC) RSC: Upper bound